Browse EV MemProt Atlas
Supporting publications (n)
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| S22AB | Q9NSA0 | Solute carrier family 22 member 11 (Organic anion transporter 4) (OAT4) (Organic anion:dicarboxylate exchanger OAT4) | FDA approved drug targetsMetabolic proteinsPlasma proteins | 12 | Clinical-translation mediationFusion and delivery mediation | 0.38 | ||||
| S22AC | Q96S37 | Solute carrier family 22 member 12 (Organic anion transporter 4-like protein) (Renal-specific transporter) (RST) (Urate anion exchanger 1) (URAT1) (Urate:anion antiporter SLC22A12) | Disease related genesFDA approved drug targetsHuman disease related genes | 12 | Clinical-translation mediationFusion and delivery mediation | 0.38 | ||||
| S22AD | Q9Y226 | Solute carrier family 22 member 13 (Organic anion transporter 10) (OAT10) (Organic cation transporter-like 3) (ORCTL-3) (ORCTL3) | Metabolic proteinsPredicted membrane proteinsTransporters | 12 | Fusion and delivery mediationImmune mediationMetabolism mediation | 0.38 | ||||
| S23A1 | Q9UHI7 | Solute carrier family 23 member 1 (Na(+)/L-ascorbic acid transporter 1) (Sodium-dependent vitamin C transporter 1) (hSVCT1) (Yolk sac permease-like molecule 3) | Metabolic proteinsPredicted membrane proteinsTransporters | 12 | Urinary tract infectionVitamin deficiency | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 0.38 | |||
| S26A4 | O43511 | Pendrin (Sodium-independent chloride/iodide transporter) (Solute carrier family 26 member 4) | Disease related genesHuman disease related genesMetabolic proteins | 12 | Clinical-translation mediationFusion and delivery mediation | 0.38 | ||||
| S27A5 | Q9Y2P5 | Long-chain fatty acid transport protein 5 (FATP-5) (Fatty acid transport protein 5) (Bile acid-CoA ligase) (BA-CoA ligase) (BAL) (Bile acyl-CoA synthetase) (BACS) (EC 6.2.1.7) (Cholate--CoA ligase) (Fatty-acid-coenzyme A ligase, very long-chain 3) (Long-chain-fatty-acid--CoA ligase) (EC 6.2.1.3) (Solute carrier family 27 member 5) (Very long-chain acyl-CoA synthetase homolog 2) (VLCS-H2) (VLCSH2) (EC 6.2.1.-) (Very long-chain acyl-CoA synthetase-related protein) (VLACS-related) (VLACSR) | EnzymesMetabolic proteinsPredicted intracellular proteins | 2 | Fusion and delivery mediationMetabolism mediation | 0.38 | ||||
| S29A2 | Q14542 | Equilibrative nucleoside transporter 2 (hENT2) (36 kDa nucleolar protein HNP36) (Delayed-early response protein 12) (Equilibrative nitrobenzylmercaptopurine riboside-insensitive nucleoside transporter) (Equilibrative NBMPR-insensitive nucleoside transporter) (Hydrophobic nucleolar protein, 36 kDa) (Nucleoside transporter, ei-type) (Solute carrier family 29 member 2) | Metabolic proteinsPredicted membrane proteinsTransporters | 11 | Clinical-translation mediationFusion and delivery mediation | 0.38 | ||||
| S36A1 | Q7Z2H8 | Proton-coupled amino acid transporter 1 (Proton/amino acid transporter 1) (hPAT1) (Solute carrier family 36 member 1) | Metabolic proteinsPredicted intracellular proteinsPredicted membrane proteins | 11 | Fusion and delivery mediation | 0.38 | ||||
| S39A4 | Q6P5W5 | Zinc transporter ZIP4 (Solute carrier family 39 member 4) (Zrt- and Irt-like protein 4) (ZIP-4) | 8 | Clinical-translation mediationFusion and delivery mediation | 0.38 | |||||
| S6A19 | Q695T7 | Sodium-dependent neutral amino acid transporter B(0)AT1 (Solute carrier family 6 member 19) (System B(0) neutral amino acid transporter AT1) | Disease related genesHuman disease related genesMetabolic proteins | 12 | Clinical-translation mediationFusion and delivery mediation | 0.38 | ||||
| SC5A2 | P31639 | Sodium/glucose cotransporter 2 (Na(+)/glucose cotransporter 2) (Low affinity sodium-glucose cotransporter) (Solute carrier family 5 member 2) | Disease related genesFDA approved drug targetsHuman disease related genes | 14 | Clinical-translation mediationFusion and delivery mediation | 0.38 | ||||
| SC5A8 | Q8N695 | Sodium-coupled monocarboxylate transporter 1 (Apical iodide transporter) (Electrogenic sodium monocarboxylate cotransporter) (Sodium iodide-related cotransporter) (Solute carrier family 5 member 8) | 13 | Fusion and delivery mediationMetabolism mediation | 0.38 | |||||
| SC5AA | A0PJK1 | Sodium/mannose cotransporter SLC5A10 (Sodium/glucose cotransporter 5) (Na(+)/glucose cotransporter 5) (Solute carrier family 5 member 10) | Metabolic proteinsPredicted membrane proteinsTransporters | 14 | Fusion and delivery mediation | 0.38 | ||||
| SL9A8 | Q9Y2E8 | Sodium/hydrogen exchanger 8 (Na(+)/H(+) exchanger 8) (NHE-8) (Solute carrier family 9 member 8) | Metabolic proteinsPlasma proteinsPredicted membrane proteins | 11 | Fusion and delivery mediation | 0.38 | ||||
| SUIS | P14410 | Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)] | Disease related genesEnzymesFDA approved drug targets | 1 | Clinical-translation mediationFusion and delivery mediation | 0.38 | ||||
| TR10A | O00220 | Tumor necrosis factor receptor superfamily member 10A (Death receptor 4) (TNF-related apoptosis-inducing ligand receptor 1) (TRAIL receptor 1) (TRAIL-R1) (CD antigen CD261) | Cancer-related genesCD markersPredicted membrane proteins | 1 | Fusion and delivery mediationImmune mediationReceptor-signaling mediation | 0.38 | ||||
| UPK2 | O00526 | Uroplakin-2 (UP2) (Uroplakin II) (UPII) | Predicted membrane proteinsTransporters | 1 | Fusion and delivery mediation | 0.38 | ||||
| ABCA8 | O94911 | ABC-type organic anion transporter ABCA8 (EC 7.6.2.-) (ATP-binding cassette sub-family A member 8) | Metabolic proteinsPredicted membrane proteinsTransporters | 14 | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 5 | 0.25 | |||
| CD1D | P15813 | Antigen-presenting glycoprotein CD1d (R3G1) (CD antigen CD1d) | Cancer-related genesCD markersPredicted membrane proteins | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 5 | 0.25 | |||
| CD36 | P16671 | Platelet glycoprotein 4 (Fatty acid translocase) (FAT) (Glycoprotein IIIb) (GPIIIB) (Leukocyte differentiation antigen CD36) (PAS IV) (PAS-4) (Platelet collagen receptor) (Platelet glycoprotein IV) (GPIV) (Thrombospondin receptor) (CD antigen CD36) | Cancer-related genesCD markersDisease related genes | 2 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 5 | 0.25 | |||
| EXTL3 | O43909 | Exostosin-like 3 (EC 2.4.1.223) (EXT-related protein 1) (Glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Hereditary multiple exostoses gene isolog) (Multiple exostosis-like protein 3) (Putative tumor suppressor protein EXTL3) | Disease related genesEnzymesHuman disease related genes | 1 | Immune mediationMetabolism mediationReceptor-signaling mediation | 5 | 0.25 | |||
| GLUT4 | P14672 | Solute carrier family 2, facilitated glucose transporter member 4 (Glucose transporter type 4, insulin-responsive) (GLUT-4) | Disease related genesMetabolic proteinsPotential drug targets | 12 | Type 2 diabetes mellitus | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 5 | 0.25 | ||
| HEG1 | Q9ULI3 | Protein HEG homolog 1 | Plasma proteinsPredicted membrane proteins | 1 | Adhesion and uptake mediationFusion and delivery mediationReceptor-signaling mediation | 5 | 0.25 | |||
| IGDC4 | Q8TDY8 | Immunoglobulin superfamily DCC subclass member 4 (Neighbor of punc e11) (Protein DDM36) (hDDM36) | Plasma proteinsPredicted membrane proteins | 1 | Other mediation | 5 | 0.25 | |||
| ITA5 | P08648 | Integrin alpha-5 (CD49 antigen-like family member E) (Fibronectin receptor subunit alpha) (Integrin alpha-F) (VLA-5) (CD antigen CD49e) [Cleaved into: Integrin alpha-5 heavy chain; Integrin alpha-5 light chain] | Cancer-related genesCD markersPlasma proteins | 1 | Allergic/hypersensitivity disorderAsthmaMultiple sclerosis | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 5 | 0.25 |